Doximity, Inc. (DOCS) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
P/E 27.76 means the share price is 27.76 times one year of earnings per share; the S&P 500 usually sits near 20-25. Market cap $4.81B is the value of all shares combined. Beta 1.42: the stock has moved about 42% more than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 9, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerDoximity, Inc. (DOCS) trades at $25.70 with MoonshotScore 93/100 (Grade A+). Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. Market cap: $4.81B, Sector: Healthcare.
Price as of Sep 11, 2026 · Last analyzed: May 9, 2026DOCS stock analysis for 2026: Analysts have set a consensus price target of $27.60 for Doximity, Inc., suggesting 7.4% upside from the current price of $25.70. The AI MoonshotScore is 93/100, in the Exceptional band (80-100) — a research signal, not a recommendation. Key factors: analyst coverage, AI-driven quantitative scoring.
DOCS: 3/3 scored disciplines lean bullish. Dominant signal: Moon AI bullish.
How is this calculated? →Strongest side: Business Quality (10/10, Strong). Weakest side: Momentum (4/10, Weak).
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Why this analysis is different
- A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Doximity, Inc. (DOCS) Healthcare & Pipeline Overview
Doximity, Inc. provides a cloud-based digital platform tailored for medical professionals in the U.S., facilitating collaboration, patient care coordination, and career management. Serving pharmaceutical manufacturers and healthcare systems, Doximity distinguishes itself through specialized tools and a focus on streamlining medical workflows within the healthcare information services sector.
What Is the Investment Thesis for DOCS?
With a market capitalization of $4.81B and a P/E ratio of 27.76, the company demonstrates strong profitability, supported by a high gross margin of 89.7% and a profit margin of 37.5%. Key value drivers include the increasing adoption of telehealth and virtual care, which fuels demand for Doximity's platform. Growth catalysts include expanding its service offerings to address additional needs within the healthcare ecosystem. Potential risks include increased competition from established technology companies entering the healthcare space and evolving regulatory landscape surrounding data privacy and security.
Based on FMP financials and quantitative analysis
DOCS Key Highlights
Market capitalization of $4.81B reflects investor confidence in Doximity's growth potential.
- P/E ratio of 27.76 indicates a premium valuation, suggesting strong earnings expectations.
- Gross margin of 89.7% demonstrates efficient cost management and pricing power.
- Profit margin of 37.5% highlights the company's ability to generate substantial profits from its revenue.
- Beta of 1.42 suggests higher volatility compared to the overall market.
Who Are DOCS's Competitors?
DOCS is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| EXAS Exact Sciences Corporation | $104.91 | 0.00% | $20.0B | — |
| VTRS Viatris Inc. | $16.49 | +0.67% | $19.2B | 335-pillar |
| COO The Cooper Companies, Inc. | $53.74 | -0.79% | $10.5B | 385-pillar |
| GH Guardant Health, Inc. | $159.03 | -2.30% | $21.3B | 355-pillar |
| SOLV Solventum Corporation | $87.80 | +0.17% | $15.2B | 595-pillar |
| HTFL HeartFlow, Inc. | $48.23 | +6.02% | $4.16B | 325-pillar |
| MTHRF M3, Inc. | $10.36 | 0.00% | $6.92B | 489-signal |
| HNGE Hinge Health, Inc. | $90.02 | +1.99% | $6.97B | 905-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.
What Are DOCS's Key Strengths?
Dominant position in the medical professional networking space.
- High gross and profit margins.
- Strong brand recognition and reputation.
- Large and engaged user base.
What Are DOCS's Weaknesses?
Reliance on advertising revenue.
- Potential for increased competition.
- Dependence on the U.S. healthcare market.
- Vulnerability to data breaches and privacy concerns.
What Could Drive DOCS Stock Higher?
DOCS catalyst: Potential partnerships with major healthcare systems to integrate Doximity's platform into their workflows by Q4 2026.
- Increasing adoption of telehealth services driving demand for Doximity's virtual visit capabilities.
- Expansion of Doximity's platform to include new features and functionalities, such as AI-powered clinical decision support tools.
- Launch of new advertising campaigns targeting specific medical specialties in Q3 2026.
What Are the Key Risks for DOCS?
Rich valuation — a P/E of 27.76 runs well above the Healthcare sector’s ~21.50x, leaving little room for a miss.
- Increased competition from established technology companies entering the healthcare space.
- Evolving regulatory landscape surrounding data privacy and security could impact Doximity's operations.
- Dependence on advertising revenue makes Doximity vulnerable to economic downturns and changes in marketing budgets.
- Data breaches and privacy concerns could damage Doximity's reputation and erode user trust.
What Are the Growth Opportunities for DOCS?
- Expansion into new specialties and subspecialties represents a significant growth opportunity for Doximity. By tailoring its platform to meet the specific needs of different medical disciplines, Doximity can attract new users and increase engagement. The market size for specialized healthcare platforms is estimated to be substantial, with potential for significant revenue growth over the next 3-5 years.
- Increasing adoption of telehealth and virtual care creates opportunities for Doximity to expand its virtual visit capabilities and integrate with telehealth platforms. As telehealth becomes more mainstream, Doximity can capitalize on the growing demand for virtual care solutions.
- Development of new features and functionalities, such as AI-powered tools for clinical decision support, can enhance the value proposition of Doximity's platform and attract new users. By leveraging artificial intelligence and machine learning, Doximity can provide medical professionals with valuable insights and improve patient outcomes. The market for AI in healthcare is rapidly expanding, presenting a significant growth opportunity.
- Strategic partnerships with healthcare systems and pharmaceutical companies can expand Doximity's reach and accelerate adoption of its platform. By collaborating with key players in the healthcare ecosystem, Doximity can gain access to new markets and customers. Strategic partnerships can also provide Doximity with valuable data and insights, enabling it to further improve its platform.
- International expansion represents a long-term growth opportunity for Doximity. By expanding its platform to other countries, Doximity can tap into new markets and diversify its revenue streams. The global market for healthcare information services is substantial, with significant growth potential in emerging markets. International expansion would require Doximity to adapt its platform to meet the specific needs of different healthcare systems and regulatory environments.
What Threats Does DOCS Face?
- Evolving regulatory landscape surrounding data privacy and security.
- Disruption from new technologies and business models.
- Economic downturn and reduced healthcare spending.
- Negative publicity or reputational damage.
What Are DOCS's Competitive Advantages?
- Network effect: The value of the platform increases as more medical professionals join and engage with it.
- Data advantage: Doximity has access to a vast amount of data on medical professionals and their interactions, which can be used to improve its platform and services.
- Brand recognition: Doximity is a well-known and respected brand among medical professionals.
- Switching costs: Medical professionals who rely on Doximity's platform for communication and collaboration are unlikely to switch to a competitor.
What Does DOCS Do?
Doximity, Inc., initially incorporated as 3MD Communications, Inc. in 2010 before rebranding, is a cloud-based digital platform catering to medical professionals in the United States. Founded in 2010 and headquartered in San Francisco, California, the company's core mission is to equip medical practitioners with tools that enhance collaboration, streamline patient care coordination, facilitate virtual patient visits, provide access to the latest medical news and research, and support career management. Doximity's platform serves as a central hub where medical professionals can connect with colleagues, securely share patient information, and engage in continuous medical education. The company primarily serves pharmaceutical manufacturers and healthcare systems, offering targeted advertising and communication solutions. Doximity's evolution reflects the increasing digitization of healthcare and the need for efficient communication and information sharing among medical professionals. Its platform has become an integral part of the daily workflow for many physicians and healthcare providers, solidifying its position in the healthcare information services sector.
What Products and Services Does DOCS Offer?
- Provides a cloud-based digital platform for medical professionals.
- Enables collaboration among medical colleagues.
- Facilitates coordination of patient care.
- Conducts virtual patient visits.
- Provides access to the latest medical news and research.
- Helps medical professionals manage their careers.
- Offers targeted advertising and communication solutions for pharmaceutical manufacturers.
How Does DOCS Make Money?
- Subscription fees from medical professionals for premium features and services.
- Advertising revenue from pharmaceutical manufacturers and healthcare systems.
- Data analytics and insights services for healthcare organizations.
- Sponsorships and partnerships with industry events and organizations.
What Industry Does DOCS Operate In?
Doximity, Inc. operates within the rapidly evolving healthcare information services sector. The industry is characterized by increasing digitization, driven by the need for improved efficiency, better patient outcomes, and reduced costs. The market is competitive, with established players and emerging startups vying for market share. Doximity differentiates itself through its focus on medical professionals and its comprehensive platform that addresses multiple needs, including communication, collaboration, and career management. The healthcare information services market is projected to continue growing, fueled by factors such as the aging population, increasing prevalence of chronic diseases, and advancements in technology.
Who Are DOCS's Key Customers?
- Medical professionals, including physicians, nurses, and other healthcare providers.
- Pharmaceutical manufacturers seeking to reach and engage with medical professionals.
- Healthcare systems looking to improve communication and collaboration among their staff.
- Recruiting firms seeking to hire medical professionals.
Research confidence
Broad, current evidence sits behind this analysis.
- ● Scored on 97% of our measures
- ● Price is current
- ● Latest filing 36 days ago
- ● Covered by analysts
Why 93?
Measured against companies in the same sector. The figures below are the factor contributions the scoring engine itself produced.
What is helping
- +0.78 Gross profit per dollar of assets (Business Quality)
- +0.44 Return on equity (Business Quality)
- +0.41 Financial-health checklist (Financial Strength)
What is holding it back
- -0.10 Distance from the 52-week high (Momentum)
- -0.10 12-month price trend (Momentum)
- -0.08 Price to book (Valuation)
Contribution = how far the company sits from its sector on that measure, weighted by how much the pillar counts. Not investment advice. How the score is built →
MoonshotScore History
Recorded daily since 2026-08-23 · 19 snapshots
| 2026-08-23 | 94 |
| 2026-08-26 | 94 |
| 2026-08-29 | 95 |
| 2026-09-01 | 93 |
| 2026-09-04 | 94 |
| 2026-09-07 | 92 |
| 2026-09-10 | 92 |
What changed?
The grade moved from 94 to 92 (-2).
What moved it up or down:
- -12 Valuation
- -2 Financial Safety
Held back by:
- +1 Growth Durability
- +1 Momentum
Over the same 18 days the stock moved -1.9%.
Doximity, Inc. Financial Trajectory
Doximity, Inc. (DOCS) reported $156.6M in revenue for Q1 FY2027, reflecting 7.7% growth compared to the prior quarter. The company recorded net income of $24.3M, with diluted EPS of $0.13. Quarter-over-quarter revenue has been mixed, typical for a mid-cap company operating in Healthcare. Across the four most recent quarters, DOCS averaged $0.21 in diluted EPS.
Company Profile
Doximity, Inc. operates in the Health Information Services industry within the Healthcare sector. It is headquartered in San Francisco, United States.
How Doximity, Inc. Is Valued
Doximity, Inc. carries a market capitalization of $4.81B, placing it in the mid-cap category. Analyst price targets span from $18.00 to $41.00, with a consensus of $27.60. At the current price of $25.70, that implies approximately 7% upside potential. Relative to its peer group, DOCS's quantitative score of 93/100 is above the peer average of 48/100.
Key Financial Metrics
Return on equity for Doximity, Inc. stands at 19.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 17.4%, showing how much profit it generates from its asset base. DOCS trades at a trailing price-to-earnings ratio of 27.76, above the Healthcare sector average of ~21.50x. Its free cash flow yield is 8.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 6.09 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 5.1%, the inverse of the P/E and a quick read on earnings relative to price.
Financial Health
Doximity, Inc.'s Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 18.16 places it in the safe zone, indicating low near-term bankruptcy risk.
Earnings Track Record
Doximity, Inc. has beaten Wall Street's EPS estimate in 6 of its last 8 reported quarters — a consistent record of delivering on expectations. Reported results have landed about 17.0% above estimates on average.
Insider Activity
Over the past six months, Doximity, Inc. insiders filed 30 SEC Form 4 transactions — 16 sales and 14 purchases. On net that is roughly 2.5M shares acquired (about $68.2M) — insiders putting money in tends to read as conviction.
DOCS Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2026
Bull Case vs Bear Case
Bull Case
- Dominant position in the medical professional networking space.
- High gross and profit margins.
- Strong brand recognition and reputation.
- Large and engaged user base.
Bear Case
- Reliance on advertising revenue.
- Potential for increased competition.
- Dependence on the U.S. healthcare market.
- Vulnerability to data breaches and privacy concerns.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · September 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 FY2027 | $157M | $24M | $0.13 |
| Q4 FY2026 | $145M | $19M | $0.10 |
| Q3 FY2026 | $185M | $62M | $0.31 |
| Q2 FY2026 | $169M | $62M | $0.31 |
Q1 FY2027 · filed 6 Aug 2026 · SEC EDGAR →
Based on FMP financials and quantitative analysis
DOCS Latest News
-
Freedom Capital Markets Downgrades Doximity to Hold, Raises Price Target to $27
benzinga · Sep 8, 2026
-
AXQ Capital LP Has $3.67 Million Stake in Doximity, Inc. $DOCS
defenseworld.net · Sep 4, 2026
-
3 Reasons to Avoid DOCS and 1 Stock to Buy Instead
Yahoo! Finance: DOCS News · Sep 1, 2026
-
Doximity Inc (DOCS) Shares Surge 4.5% -- What GF Score of 86 Tells Investors
gurufocus.com · Aug 28, 2026
DOCS Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for DOCS.
Price Targets
Median: $26.00 (+7.4% from current price)
Source: FMP analyst consensus · as of Sep 10, 2026 · an estimate, not advice
DOCS MoonshotScore
What does this score mean?
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. DOCS scores 93/100 (Grade A+): the number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.
Latest News
Freedom Capital Markets Downgrades Doximity to Hold, Raises Price Target to $27
AXQ Capital LP Has $3.67 Million Stake in Doximity, Inc. $DOCS
3 Reasons to Avoid DOCS and 1 Stock to Buy Instead
Doximity Inc (DOCS) Shares Surge 4.5% -- What GF Score of 86 Tells Investors
Leadership: Jeffrey A. Tangney
CEO
Jeffrey A. Tangney is the Chief Executive Officer of Doximity, Inc. He has extensive experience in the healthcare technology industry. Prior to Doximity, Tangney co-founded Epocrates, a leading provider of mobile drug reference tools for healthcare professionals. He holds a Bachelor of Science degree in Electrical Engineering from the University of Michigan and an MBA from Stanford University. Tangney's leadership has been instrumental in driving Doximity's growth and success.
Track Record: Under Jeffrey Tangney's leadership, Doximity has achieved significant milestones, including its successful IPO and expansion into new markets and service offerings. He has overseen the development of innovative features and functionalities that have enhanced the value proposition of Doximity's platform. Tangney has also fostered a strong company culture focused on innovation and customer satisfaction.
Doximity, Inc. Healthcare Stock: Key Questions Answered
What does the AI Score mean for DOCS?
DOCS holds an AI Score of 93/100 (Grade: A+). This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers. Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States.
Is DOCS a good stock?
Stock Expert AI does not rate DOCS buy, sell or hold. Doximity, Inc. carries a MoonshotScore of 93/100 on the five-pillar engine, a research rating against its peers. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.
What do analysts say about DOCS stock?
Analyst consensus on DOCS stock is mixed, with some highlighting the company's strong growth potential and dominant position in the medical professional networking space. Key valuation metrics, such as the P/E ratio, suggest a premium valuation, reflecting high expectations for future earnings growth.
What are the key factors to evaluate for DOCS?
Doximity, Inc. (DOCS) holds a MoonshotScore of 93/100 (high). P/E: 27.76x vs the S&P 500's ~20-25x. Analysts target $27.60 (+7%). Not financial advice.
How frequently does DOCS data refresh on this page?
DOCS's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven DOCS's recent stock price performance?
Doximity, Inc. (DOCS) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Dominant position in the medical professional networking space. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider DOCS overvalued or undervalued right now?
Doximity, Inc. (DOCS) trades at 27.76x earnings. Analysts target $27.60 (+7%) — near fair value. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of DOCS?
Yes, most major brokerages offer fractional shares of Doximity, Inc. (DOCS) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track DOCS's earnings and financial reports?
Doximity, Inc. (DOCS) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for DOCS earnings announcements.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may be subject to change.
- Financial metrics are as of the latest reporting period.